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Abstract

Structural Homology of Alpha and Beta Subunits
of the GABAa/Benzodiazepine Receptor as Demonstrated
by Monoclonal Antibodies and Limited Proteolysis

Robert Thomas Malison
1987

Molecular aspects of GABAa/benzodiazepine receptor structure,
including putative receptor heterogeneity, were studied.

Using

affinity chromatographic techniques, a partially purified
benzodiazepine receptor preparation was obtained from rat brain.

A

major protein band of 48.5 kD and several minor bands (68, 58, 54.5,
and 50 kD) were isolated.

Electrophoretic analysis in one and two

dimensions demonstrates co-localization of this 48.5 kD protein with
the photo-labeled alpha subunit.

Using this benzodiazepine receptor

preparation, 6 murine monoclonal cell lines were generated, as tested
for by solid phase radioimmunoassay.
proteins

Western blots to receptor

separated electrophoretically demonstrate the presence of

two immunoreactive bands of 48.5 and 54.5 kD, corresponding to the
alpha and beta subunits.

Specificity

of one monoclonal antibody, E9,

for the alpha subunit (48.5 kD) was confirmed by two dimensional
gel electrophoresis.

Immunoblot studies using another monoclonal

antibody, H10, suggest
subunits.

a common epitope is shared by both

The molecular basis underlying subunit relatedness was

explored by limited protelytic degradation of the iodinated
iii

benzodiazepine receptor preparation.

Results indicate that

degradation of both 48.5 kD and 54.5 kD proteins yielded several
shared limiting peptides as determined by molecular weight.
Homology of these receptors may, thus, exist at the level of primary
protein structure.
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Introduction

Gamma-aminobutyric acid (GABA), an inhibitory
neurotransmitter, is widely distributed in the mammalian central
nervous system.

Concentrations in the human brain, though

regionally variable, are measured in pmoles/gram, three orders of
magnitude greater than concentrations typical of the monoamines
(Fahn and Cote, 1968).

Estimates suggest that GABA may be a

neurotransmitter at 30% of synapses in the brain.

The primary

action of GABA is inhibitory, resulting in an increased chloride flux
across and subsequent hyperpolarization of neuronal cell membranes
(Krnjevic,1974; Curtis & Johnston,1974).

With recognition of its role

as one of the brain's major inhibitory transmitters, substantial efforts
have been made to implicate GABA in the pathophysiology of
numerous neurologic and psychiatric disorders, including epilepsy
(Olsen et al, 1985), Huntington's disease (Van Ness et al, 1982),
affective disorders (Emrich et al, 1980), and anxiety (Tallman et al,
1980).
Various lines of investigation have shown that a host of
compounds, including the 1,4-benzodiazepines, are capable of
modifying post-synaptic responses to GABA.
electrophysiologic

Specifically,

studies demonstrated enhanced GABA-ergic

transmission in the presence of benzodiazepines (Schmidt et al, 1967;
review by Tallman et al 1980 & Haefley et al, 1981).

Investigations

into the molecular basis for the benzodiazepine's effect resulted in
the demonstration of a high-affinity binding site (receptor) in the
CNS (Squires & Braestrup, 1977; Mohler & Okada, 1977).

Binding
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studies in vitro fulfill criteria for a pharmacologic receptor; namely,
binding is rapid, reversible, stereospecific and saturable.

In addition,

the rank order potency of benzodiazpines’ ability to displace
diazepam from this central site correlates significantly with both
activity in animal behavioral tests predictive of benzodiazepine
potency (Braestrup & Squires, 1978; Mohler & Okada, 1978) and
therapeutic doses in humans (Tallman et al, 1980).
This high affinity central receptor has been shown to be
functionally linked to the chloride channel-linked GABA receptor,
known as the GABAa receptor (a second, G-protein-linked GABAb
receptor has been described by Bowery & Hill, 1980, and is not
associated with benzodiazepine binding).

Binding of GABA and

related agonists to a low affinity (1-5 pM) site on this GABAa
receptor complex facilitates the binding of benzodiazepines (Tallman
et al, 1978).
(+)bicuculline.

This binding is blocked by the GABA antagonist
Thus, the central binding sites for both GABA and the

benzodiazepines appear to be allosterically linked and most likely
reside within the same protein complex.
As research into the molecular nature of the GABAa
/benzodiazepine receptor complex has progressed, the existence of
benzodiazepine receptor subtypes in different brain regions has been
hypothesized (Seighart & Karobath, 1980).

Initial evidence

supporting this hypothesis came from binding studies

using the

triazolopyridazine, CL218,872, a compound shown to interact at the
benzodiazepine receptor.

Results were consistent with receptor

heterogeneity or negative cooperativity in a number of brain regions,
most notably the hippocampus (Squires et al, 1979; Klepner et al,
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1979).

Autoradiographic localization at the light microscopic level

supported a heterogeneity of receptors, as well (Young & Kuhar,
1980; Young et al, 1981; Niehoff et al, 1982).
In addition to pharmacologic and autoradiographic lines of
evidence, photo-labeling

studies with

several photo-activated

compounds have pointed to a structural heterogeneity of receptor
subtypes at the molecular level.

Early alkylating compounds,

irazepine (Rice et al, 1979) and kenazepine (Williams et al, 1980),
were able to distinguished between apparently different receptor
subtypes (Skolnick et al, 1982).
benzodiazepine,

Introduction of the nitro-containing

[3H]-flunitrazepam, not only enabled the

autoradiographic localization studies mentioned above, but also
allowed electrophoretic analysis of the molecular structure of the
benzodiazepine receptor under denaturing conditions.

Such photo¬

labeling experiments have demonstrated the existence of a major
band, the alpha subunit, in rat brain with a molecular weight of
approximately 50 kD (Mohler et al, 1980; Thomas & Tallman, 1981).
A second protein band on acrylamide gels, the beta subunit,
demonstrates a molecular weight of approximately 55 kD.

It appears

to exist in hippocampus and striatum (Sieghart & Karobath, 1980;
Sieghart et al, 1983), as well as being expressed early in postnatal
development (Eichinger & Sieghart, 1986).

Additional minor bands

of 53 kD and 59 kD have also been described (Sieghart et al, 1983).
The relationship of these various proteins to the GABAa
/benzodiazepine receptor complex and to one another remains to be
defined.
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With improved affinity chromatography and specific ligand
elution methods, significant purification of benzodiazepine receptor
subtypes has been achieved (Ransom et al, 1986; Sigel et al, 1983;
Schoch et al, 1984; Tallman & Gallager, 1979).

Using rat cortex, a

partially purified benzodiazepine receptor preparation was obtained.
In this preparation a major protein band of 48.5 kD and several
minor bands (68, 58, 54.5, and 50 kD) were isolated.

Analysis of the

48.5 kD protein in two dimensions shows it to co-localize with the
photo-labeled alpha subunit.

Using this benzodiazepine receptor

preparation, 6 murine monoclonal cell lines were generated, as tested
for by solid phase radioimmunoassay.

Western blots to receptor

proteins separated electrophoretically demonstrate the presence of
two immunoreactive bands of 48.5 and 54.5 kD.

These results are

similar to those observed in bovine brain (Haring et al, 1985).

In

addition, immunoblot studies using one monoclonal antibody, H10,
suggest

a common epitope is shared by both subunits.

In an

attempt to further delineate the molecular structure and to explore
the possibility that homology between the alpha and beta subunits of
the GABAa/benzodiazepine receptor exists, these proteins were
analyzed by methods of limited proteolysis.

Results indicate that

degradation of both 48.5 kD and 54.5 kD proteins yielded several
limited peptides as determined by molecular weight.

Homology of

these receptors may, thus, exist at the level of primary protein
structure.
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Materials & Methods

Benzodiazepine Receptor Purification
Purification of the benzodiazepine receptor was carried out by
affinity chromatographic methods utilizing a benzodiazepine coupled
agarose resin.

Preparation of the ligand affinity column and isolation

of the benzodiazepine receptor have been discussed in detail
elsewhere (Ransom et al, 1986; Sigel et al, 1983; Schoch et al, 1984;
Tallman & Gallager, 1979).

Briefly, the flurazepam derivative, R07-

1986/001, was coupled to an agarose gel support at the carboxyterminus of a positively charged 15-atom spacer arm (succinylmethylimino-bis-propylamino

carboxylmethyl

agarose

carboxamide).

A volume of 100 ml of the N-hydroxysuccinimide ester of this gel
(Affi-Gel 15, Bio-Rad) was washed with absolute ethanol and
suspended in al50 ml volume.

The agarose was reacted with 100

mg of ligand at 4° C overnight.

The coupled gel was washed with 1

liter of distilled water using a sintered glass funnel under light
vacuum.

The agarose gel was resuspended in 25 mM potassium

phosphate buffer at pH 7.3 and filtered just prior to use.
Whole rat brain was homogenized inlO volumes of 25 mM
potassium phosphate buffer containing 0.1 mM
phenylmethylsulfonylfluoride (PMSF),

2.5

pg/ml trypsin inhibitor, 5

mM ethylene-diamine-tetraacetic acid (EDTA) and 50 pM
benzamidine at pH=7.3 (PIB) using a Polytron tissue homogenizer
(Brinkman

Instruments). The homogenate was then centrifuged at

40,000 x g for 20 minutes and the pelleted membranes homogenized
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and centrifuged twice more in the same manner.

The washed pellets

were then frozen overnight at -80° C.
The following morning, pellets were again homogenized and
centrifuged in the same buffer twice.
suspended in

The membranes were

10 volumes of 1.0% Lubrol PX (Sigma Chemical

Company) in PIB and stirred at 4° C for 1 hr.

The solubilized

membrane suspension was ultracentrifuged at 105,000 x g for 30
minutes.

Supernatants were pooled and stirred with the R07-

1986/001 coupled agarose (approx. 3:1, V/V) for 1 hr. at 4 ° C.

The

Affigel was washed and filtered 2 times with 1.0% Lubrol PX and 4
times

with

5

mM

3-(chloramidopropyldimethyl-amino)-l-

propansulfonate (CHAPS) in comparable volumes.

The

benzodiazepine receptor was eluted from the Affigel overnight
with 1.0 mM Flurazepam in PIB with CHAPS at 4 ° C.
The next morning the Affigel was filtered and the filtrate
dialyzed against 1 liter of PIB with CHAPS using an Amicon filtration
apparatus (membrane size PM30).

Following the dialysis, the

receptor mixture was then concentrated to a final volume of 2-3 mis
and stored at - 80 ° C for future use.

The benzodiazepine coupled

Affigel was washed with a generous volume of distilled water and
stored for reuse in 70% ethanol at 4 0 C.
The partially purified benzodiazepine receptor preparation was
further purified by gel exclusion chromatography.

Sephadex

G-200

resin (Pharmacia) was preswollen for 48 hours in distilled water, a
200 ml bed volume poured, and the column eluted with 2 column
volumes

of 5

acid (HEPES).

mM

N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic

A 2.0 ml sample of the purified benzodiazepine
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receptor preparation (as described above) containing

1

mg/ml

Dextran-2000 Blue was applied to the column and eluted with 5 mM
HEPES at 4 ° C.

Fractions of 1.0 ml were collected and 10 pi samples

of each fraction analyzed by gel electrophoresis.

Samples enriched in

the benzodiazepine receptor (48.5 kD band) were pooled and
lyophilized.

Anti-Benzodiazepine Receptor Antibody Screening bv Solid Phase
Radioimmunoassay
Initial screening of polyclonal and monoclonal antibody titers
was carried out by a previously described solid phase
radioimmunoassay (Kun et al, 1978).

Briefly, 50 pi of receptor

preparation at a concentration of approximately 1 pg/ml was
passively absorbed to polyvinyl chloride microtiter wells
(approximately 0.05 pg receptor protein).
blocked with

Unreacted sites were then

a 5% solution of bovine serum albumin (BSA).

Polyclonal serum or monoclonal supernatant was then incubated
wells for 24 hours at 4 ° C.

in

After extensive washing, wells were then

reacted at room temperature for 2 hours with 125I-goat
IgG having a specific activity of 500,000 cpm/ml.

anti-mouse

Following

extensive washing, wells were then counted in a Beckman Model
5000 gamma counter.

Production of Monoclonal Antibodies
Monoclonal antibodies to the benzodiazepine receptor were
produced using the methods originally described by Kohler &
Milstein (1975) with modifications (Kohler, 1980).

Female BALB/c

8
mice, ages 18-20 weeks, were injected intraperitoneally with
purified benzodiazepine receptor preparation according to the
following schedule:

Week 1, 75 pg receptor protein in 0.5 mis

Freund's complete adjuvant; Week 2, 50 pg receptor protein in 0.5
mis Freund's incomplete adjuvant; Week 3, 50 pg receptor protein in
250 pi 25 mM potassium phosphate buffer, pH 7.3.

Mice were bled

retroorbitally and the serum polyclonal antibody titer determined by
solid phase radioimmunoassay as described above.
Two days after final injection, mice with the highest polyclonal
titers were sacrificed and spleens dissected under sterile technique.
Splenic lymphocytes from a single mouse were suspended in 10 mis
Hank's Balanced Salt solution (Gibco) and pelletted.
cm2 tissue culture flask

One confluent 75

of the non-secreting myeloma cell line, AG6-

53 (obtained from Dr. E. Hawrot, Yale), was pelleted, washed, and
recentrifuged in an identical fashion.

Cells were then co-suspended

in 20 mis of Hank's ,pelleted, and the supernatant discarded.

Cells

were resuspended in a minimal volume of Hank's by gentle agitation
and 1.0 ml of 50% polyethylene glycol (Sigma Chemical Company,
3000-3700) added dropwise over 1 minute with gentle swirling.

In

a similar fashion, a total volume of 20 mis of high glucose formula
Dulbecco's Minimum Essential Medium (DMEM) supplemented with
10% fetal calf serum, 50 pM hypoxanthine, 0.2 pM aminopterin, and
8 pM thymidine (Sigma Chemical Company) was added.

Cell

suspensions were then aliquoted dropwise in 96 well microtiter
plates from which hybridoma lines were selected.

Clones testing

positive to receptor preparation by solid phase radioimmunoassay
were expanded in 75 cm2 tissue culture flasks using high glucose
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DMEM supplemented with 10% fetal calf serum and 50 jiM
hypoxanthine and 8 pM thymidine.
High titer ascitic fluid was produced by passing positive
hybridoma cell lines into syngeneic mice by intraperitoneal injection.
Mice were initially primed with intraperitoneal injection of 0.5 ml of
pristane five days before injection of approximately 4 x 106 cells in
1.0 ml serum free medium.

Ascitic fluid obtained by paracentesis

was stored at -80 ° C.

Gel Electrophoresis
Separation of receptor proteins for molecular weight
determination,

analysis by immunoblot,

2-dimensional

electrophoretic analysis, and limited proteolytic digestion was
attained utilizing a discontinuous sodium dodecyl sulfate (SDS)
polyacrylamide gel system as described by Laemmli (1970).
Routinely, 7.5% acrylamide separating gels were used for analysis of
purified benzodiazepine receptor preparations and western blotting,
whereas 15% gels were required for resolution of peptide fragments
derived from limited proteolysis.

Prior to application on gels,

samples were boiled for 5 minutes in 0.2 M Tris, pH 6.8, containing
2-mercaptoethanol, 10% glycerol, 2.3% SDS and 0.001 % bromphenol
blue.

Low molecular weight standards (Dalton VII-L, Sigma) were

used to determine approximate molecular weights of receptor
proteins and proteolytic fragments.

Gels were stained in a solution of

0.25% Coomassie brilliant blue, 50% methanol, 10% acetic acid on an
Eberbach clinical rotator.

Subsequent destaining of gels was carried

out with rotary shaking in a solution of 50% methanol, 10% acetic
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acid.

As needed for preservation or autoradiography, gels were

dryed on chromatography paper (Whatman 3mmChr)

at 80 0 C for 2

hours under vacuum using a slab gel dryer (Bio-Rad, Model 224).
For autoradiography, dried gels were placed against Kodak X-omat
film in an intensifying cassette for 72 hours at -80 ° C.

Screening of Monoclonal Antibodies bv Western Blotting
Either washed membrane or purified receptor preparations
were run on 7.5% polyacrylamide slab gels as described above.
Separated proteins were then transferred to nitrocellulose paper by
high-intensity transverse electrophoresis for 2 hours at 1.0 A

in a

buffer containing 25 mM Tris, 192 mM glycine and 20% (V/V)
methanol (Towbin et al, 1979).

Unreacted sites on the nitrocellulose

paper were blocked by three 10-minute incubations in 10 mM
phosphate buffered saline, 140 mM NaCl, pH 7.4 with 0.05% Tween
(PBS/Tween).

Primary incubation of ascitic fluid at a dilution of

1:1000 in PBS/Tween was performed overnight at 4 0 C.

The

nitrocellulose was then washed at room temperature with
PBS/Tween to eliminate unreacted primary antibody.
secondary incubation

For the

125I-sheep anti-mouse IgG was used at a final

specific activity of 750,000 cpm/ml for 2 hours.

This was succeeded

by 3 more 10-minute incubations in PBS/Tween.

The nitrocellulose

was then allowed to air dry, placed against Kodak X-omat film and
loaded in an intensifying cassette for up to 18 hours at -80 ° C.
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Iodination of the Benzodiazepine Receptor
Iodination of the purified benzodiazepine receptor preparation
was carried out by the method described by Bolton and Hunter
(1973) with the following modifications:

250 pC 125I-Bolton/Hunter

reagent (125I-BH, New England Nuclear) was gently concentrated to
dryness using a dessicant-filtered N2 stream (15 min.).
Approximately

10 pg of lyophilized receptor protein in 25 pi

mM Na2HP04 , pH 8.0

of 100

was then added to the 125I-BH vial and the

reaction carried out for 30 min. at 0 ° C.

Unreacted 125I-BH was

removed by adding 400 pi of 0.2 M glycine in 100 mM Na2HP04 , pH
8.0 and allowing the reaction to proceed another 5 minutes.

The

reaction mixture was then chromatographed on a Sephadex

G-50

(fine) column using a solution of 50 mM Na2HP04 , pH 7.4 containing
0.25 % gelatin, 0.02 % NaN3 , and 0.1 % SDS as eluant.
200 pi were collected.

Fractions of

Aliquots (5 pi) of each fraction were counted

on a Beckman Model 5000 gamma counter.

Radioactive fractions

were then subjected to gel electrophoresis, and autoradiography, as
described above.

Fractions containing 125I-labeled

benzodiazepine

receptor were then aliquoted into 100 pi volumes and stored at - 80

°C

Peptide Mapping bv Limited Proteolysis
Peptide mapping of the benzodiazepine receptor was carried
out by limited proteolysis as described by Cleveland, et al (1977)
with the following modifications.

This 125I-BZR

benzodiazepine

receptor preparation was first subjected to gel electrophoresis on a
7.5% polyacrylamide gel as described above.

Visualization by
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coomassie blue staining was enabled by the addition of "cold" carrier
receptor, as necessary.

Protein bands were then cut from the slab

gel and the gel slices washed with agitation for 30 minutes in 125
mM Tris-HCl, pH 6.8 containing 0.1% SDS (Tris buffer).

Gel pieces

were then applied to the wells of a long SDS-polyacrylamide gel (4.5
cm, 3% stacking gel; 11.5 cm, 15% separating gel).

Gel slices were

then overlayed with approximately 50 pi of Tris buffer containing
20% glycerol (V/V) and a trace of bromphenol blue.

Staphylococcus

aureus V8 protease (Sigma) was diluted in Tris buffer containing 10%
glycerol (V/V) and a trace of pyronin Y.

The desired amount of

protease solution (0.001 - 0.1 pg) was layered on top and the protein
subjected again to electrophoresis overnight at 60 V.

Gels were dried

and placed against Kodak X-omat film in an intensifying cassette for
72 hours at -80 ° C.

Two Dimensional Gel Electrophoresis
This method makes use of the substitution of a nonionic
detergent for SDS, thus allowing isoelectric focusing in the first
dimension before size separation in the second.

Samples (20 pi) of

125I-labeled benzodiazepine receptor were brought to a final volumn
of 80 pi with a solution containing 9.0 M urea, 4% NP-40 (nonidet P40, Sigma), 2% ampholines pH 3-10 (Biorad), and 5%
mercaptoethanol.

6-

The samples were then subjected to 2D

electrophoresis according to the procedure described by O'Farrell
(1975), and modified by Ames & Nikiado (1976); 7.5% acrylamide
gels were used for the second dimension as described above.

4?1
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Results

Receptor Purification & SDS-PAGE Analysis
Benzodiazepine receptor was initially purified from rat cortical
membranes by affinity chromatography.

Results of SDS

electrophoretic analysis of this partially purified benzodiazepine
receptor preparation are seen in Figure 1.

Several protein bands

ranging in molecular weight from 45 to 68 kD are visualized by
coomassie blue staining.

Of these, 48.5 kD and 68 kD bands

represent the major protein constituents.

In addition to these bands,

proteins of molecular weights 50 kD, 54.5 kD, and 58 kD copurify by
affinity chromatography.

A fifth minor protein band weighing 45 kD

represents the major phosphoprotein in this preparation and has
been implicated to be the enzyme pyruvate dehydrogenase (Gallager,
Sweetnam, and Tallman, in preparation).

In addition, there exist

other minor bands of higher (70-90 kd) and lower (<35 kD)
molecular weights.
Gel filtration chromatography (G-200) of the partially purified
benzodiazepine receptor preparation resulted in fractions of varying
protein composition as evidenced by SDS gel electrophoresis (Figure
2).

Fractions enhanced in the major protein bands (48.5 kD, 54.5 kD,

58 kD, and 67 kD) eluted early with the Blue Dextran front and were
pooled for iodination and subsequent proteolytic analysis.
Interestingly, the 50 kD protein eluted later and was pooled
separately.

Figure 3 illustrates the relative purification of the
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receptor preparation with elimination of the 50 kD and lower
molecular weight proteins.

Monoclonal Antibodies & Immunoblot Analysis
Balb-C mice were successfully immunized using the
benzodiazepine receptor preparation as indicated by solid phase RIA
(Figure 4).

Three animals with the highest polyclonal titers were

sacrificed for splenic lymphocytes and cell lines established as
described in Materials & Methods.

Following 7-10 days in culture,

solid phase RIA demonstrated antibody positive cell lines with
counts of 800-1500, whereas supernatants from lines not producing
anti-benzodiazepine receptor yielded background values of 400-500.
Positive lines were retested and then expanded in tissue culture
flasks.

In total, 6 cell lines secreting anti-benzodiazepine receptor

antibodies were passed into mice and high titer ascitic fluid
prepared.

Figure 5 shows the solid phase RIA data of diluted ascites

against a limited receptor concentration (upper limit of assay
approximately 1500 cpm).

Ascitic fluid tested positive in all cases

and at dilutions of 1:10,000 in the case of some cell lines (e.g. E9, D5,
and B2).
Following initial screening by solid phase RIA, specificity of
antibodies was determined by Western blot analysis.

Immunoblots

of ascitic fluid demonstrated two distinct binding patterns, as
characterized by the cell lines E9 and H10.

As seen in Figure 6, E9

primarily labels a protein of molecular weight 48 kD - 50 kD.

Ascites

from cell line H10, in addition to labeling the protein band at 48 kD 50 kD, demonstrated recognition of a band of 55 kD.

Both antibodies

■
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appeared to demonstrate minor labeling of a protein of molecular
weight 45 kD.

Monoclonal antibodies from cell lines B2 and D5 shared

binding patterns similar to E9, whereas A2 duplicated immunoblots
seen with H10.

Western blot analysis in the ensuing data is

comprised of the two representative cell lines E9 and H10.

Iodination of the BZR
Purified benzodiazepine receptor obtained by affinity and gel
exclusion chromatography methods served as substrate for
iodination.

Following conjugation of 125I-Bolton/Hunter (125I-BH)

reagent to 10 pg of the reconstituted receptor lyophilizate, the
iodination mixture was subjected to Sephadex G-50 chromatography
with the elution of 2 major radioactive peaks (figure 7).

Analysis of

the fractions by SDS acrylamide electrophoresis and autoradiography
(Figure 8) demonstrated the first of these to represent the 125I-BHlabeled receptor preparation (125I-BZR).

Electrophoresis and

autoradiography of fractions comprising the second, larger
radioactive peak failed to demonstrate any protein bands.
likely that this peak represents 125I-BH-conjugated

It is most

glycine.

Radioactivity incorporated into the benzodiazepine receptor fraction
represented less than 5% of the starting 250 pCi total.

Limited Proteolytic Map of the 125I-BZR
Iodination of the receptor preparation yielded 4 major
radioactive bands in the region of the suggested receptor subunits.
These corresponded to the 48.5kD, 54.5 kD, 58 kD and the 68 kD
bands.

These bands were subjected to limited proteolytic
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degradation using increasing concentrations of Staph, aureus V8
protease (SAP).

A sufficient

concentration range of protease was

employed to digest major bands completely into (SAP) limiting
peptide fragments.

Conditions employed, nevertheless, utilized small

amounts of SAP, as all bands seemed sensitive to the protease
(optimum range of 0.001 - 0.03 jig).

Proteolytic fingerprints

generated for each of the major bands are illustrated in Figures 9
and 10.
Once the conditions for limited proteolysis were optimized, a
second digest experiment was conducted in an attempt to compare
proteolytic fingerprints.

In this experiment, each of the individual

protein bands were run in adjacent lanes and subjected to enzymatic
degradation with an identical amount SAP (0.001 and 0.01 jllg).
Comparison of neighboring proteolytic fingerprints was thus
facilitated (Figure 11).

2-Dimensional Gel Analysis
The iodinated benzodiazepine receptor preparation was
subjected to two dimensional electrophoresis as demonstrated in
Figure 12.

The experiments were performed in quadruplicate, in the

presence and absence of molecular weight/isoelectric standards.
addition,

In

125I-labeled benzodiazepine receptor preparation was run

separately in the second dimension for reference.

Results indicated

that the four major protein bands (48.5 kD, 54.5 kD, 58 kD, and 67
kD) focused within the experimental pH range of 7.0 - 4.5.
Isoelectric focussing revealed the 54.5 kD and 58 kD bands to be
comprised of more than one protein constituent

The two 58 kD
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constituents demonstrated nearly identical pi's to those of two 54.5
kD proteins (approximately 6.0).

In addition, isoelectric focussing of

the 54.5 kD band reveal it to be comprised of a larger, slightly more
basic protein having an apparent pi of 6.5 - 7.0.

67 kD and 48.5 kD

bands were slightly more acidic, with pi's of 4.7 and 4.8,
respectively.

Apparent molecular weights and isoelectric points of

all bands were unchanged by the presence of the protein standards.
Electrophoretic analysis in two dimensions enabled comparison
of the iodinated benzodiazepine receptor preparation to receptor
preparation subjected to coomassie blue staining and E9
immunoblotting, as well as

to rat cortical membranes subjected to

photolabeling with 3H-Flunitrazepam (Figures 13 & 14).

The

apparent molecular weight and isoelectric point of the 48.5 kD band
were similar to those of the immunoreactive and photolabeled
protein.

These were in agreement as well with the coomassie blue

stained major protein.
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Discussion
In recent years, extensive investigation into the GABAa
receptor has lead to a fuller understanding of its molecular structure
and function.

It has become increasingly clear that GABA-ergic

transmission occurs when GABA binds to a post-synaptic receptor,
resulting in increased chloride flux through an associated protein
channel.

The 1,4- benzodiazepines bind directly to this complex,

increase the likelyhood of channel opening in response to GABA
binding (Choi et al, 1981), and thus, serve to enhance GABA-ergic
activity.

Binding has been shown to be rapid, reversible, and

saturable, as well as to be influenced by the presence of GABA.

The

complex has thus been referred to as the GABAa/benzodiazepine
receptor.

A variety of molecular approaches, including affinity

purification, electrophoretic analysis,

and photo-labeling experiments

have been used in an attempt to elucidate the proteins associated
with this complex.

Such approaches have revealed two different

benzodiazepine binding proteins associated with the GABAa receptor
having molecular weights of 50 and 55 kD, respectively.

Further

studies using antibodies specific for these proteins have lead to their
respective description as the alpha and beta subunits of the
GABAa/benzodiazepine receptor complex.

The relationship between

these proteins remains to be clarified.
In this paper, aspects of the molecular structure, including the
putative heterogeneity of the benzodiazepine receptor were studied.
Various methods of investigation in addition to those above were
employed, including proteolytic mapping, and molecular studies
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using monoclonal antibodies.

Experimental results using these

combined modalities suggest, rather, that some structural similarity
among receptor subunits may exist.
Initial detergent extraction with Lubrol PX has been previously
shown to differentially solubilize the "central" or clonazapam
specific/GABA-enhanced benzodiazepine binding site from a
"peripheral" receptor (defined by high affinity binding of the
benzodiazepine analog R05-4864 ) (Yosufi et al, 1979).

This partial

purification results in an 800-1000 fold increase in benzodiazepine
binding activity over crude homogenates.

This activity is

characterized by high-affinity (<10 nM) binding sites for both
benzodiazepine agonists (3H-Flunitrazepam) and antagonists (R0151788),

as well as both high and low affinity sites for GABA.

In

addition to co-purification of the benzodiazepine and GABA sites,
enhancement of benzodiazepine binding by GABA in such
preparations has been demonstrated as well, indicating preservation
of allosteric properties of the complex.
Analysis of this partially purified benzodiazepine receptor
preparation by SDS gel electrophoresis and coomassie blue staining
reveals the presence of multiple protein bands (48.5 kD, 50 kD, 54.5
kD, 58 kD, and 68 kD).

The major band in this preparation, 48.5 kD,

has been shown to co-migrate on polyacrylamide gels with the major
photo-labeled species (data not shown), and is thought to represent
the alpha subunit of the GABAa receptor.
analysis of the receptor preparation using
electrophoresis.

This was confirmed by
2-dimensional

This technique enables resolution of proteins based

not only on molecular weight, but also on the basis of the protein's

.
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isoelectric point (pi).

Autoradiography of the 125I-labeled

benzodiazepine receptor preparation demonstrated a spot with an
apparent molecular weight of 48.5 kD and a pi of approximately 4.8.
This coincided with findings demonstrating co-localization in 2dimensions of both the coomassie blue stained protein and

the

photo-labeled receptor (Mr=48.5 kD, pi approximately 4.8).

Barnard

(1984) has previously reported the pi of the GABA/benzodiazepine
receptor complex as 5.6, though isoeletric focusing of individual
subunits has yet to be reported.

In the literature, there remains a

variety of apparent molecular weights described as representing the
major photo-labeled moiety ranging from 48.5 - 53 kD (Sigel et al,
1983; Kuriyama et al, 1984; Sigel & Barnard, 1984; Mohler et al,
1984; Fischer & Olsen, 1986).

Part of this variability may be

explained by the different species studied (e.g. rat, bovine), or may
represent differences in electrophoretic techniques, including the
composition of gels (percentage of acrylamide) and electrophoresis
time.

Two other bands of apparent molecular weight 55 kD and 47

kD incorporate relatively minor amounts (<5%) of 3H-flunitrazepam
under optimal conditions for photo-activation (Sweetnam, Nestler, &
Tallman, in preparation).

These were detectable only by gel slice

techniques and were not visualized by fluorography.

Sieghart &

Karobath (1980) have reported receptor heterogeneity for the
benzodiazepines by covalent labeling of bands with apparent
molecular weights of 50 kD, 53 kD, 55 kD, and 59 kD using the photoactivated nitrogen containing benzodiazepine, 3H-flunitrazepam.

No

attempt to inhibit proteolysis was made in these experiments, and
endogenous proteases shown to be present in membrane fractions
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(Klotz et al, 1984) might account for this observed heterogeneity.
Several protease inhibitors (benzamidine, soybean trypsin inhibitor,
and PMSF) are employed in our purification protocol.

For this reason

it is unlikely that endogenous proteolytic activity contributes to our
photo-labeling results.

We routinely label only one major protein

band in our preparation corresponding to the alpha subunit.
Monoclonal antibodies to the rat benzodiazepine receptor were
raised in mice using the partially purified receptor preparation.
Techniques using secondary antibody recognition suggest these
antibodies to be of the IgM subclass (Sweetnam, personal
communication).

This would be consistent with the rapid

immunization and harvesting schedule utilized in our protocol.

As

demonstrated by immunoblotting techniques to both purified
receptor and whole brain homogenates, our monoclonal antibodies
demonstrate specificity for the major receptor band of 48.5 kD (50 k
band or alpha subunit).

2-Dimensional electrophoretic analysis has

confirmed the specificity of monoclonal line Eg for the alpha subunit.
Western blots to 2-D gels using E9 show recognition of a protein with
apparent molecular weight of 48.5 kD and an isoelectric point of
around 4.8 (as described above).
Several of the monoclonals, as typified by H10, recognize a
second higher molecular weight species of approximately 55 kD on 1dimensional gels.

Subsequent subcloning of these cell lines has

confirmed that a single antibody is responsible for the recognition of
both bands.

The molecular basis for this dual recognition remains at

the present uncertain.

Gallombardo (in press) has shown H10 (and

E9) capable of increasing the affinity of the membrane bound

■
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receptor for 3H-Flunitrazepam,

3H-R015-1788 and 3H- muscimol.

In

light of these binding studies to membrane bound receptor,
immunoblot data suggests a common cell surface determinant on
both 48.5 kd and 55 k bands.

However, the molecular basis for this

shared epitope cannot be inferred from immunoblot data alone.
With the recent generation of monoclonal antibodies to the
bovine benzodiazepine receptor, Mohler and colleagues have utilized
similar techniques to explore the molecular structure of the
benzodiazepine receptor (Haring et al, 1985).

Results in the rat are

identical to those obtained using the bovine benzodiazepine receptor.
Immunoblot analysis revealed the existence of immunoreactive
proteins of 50 and 55 kD in all brain regions examined.
As stated above, the existence of multiple, heterogeneous
"central-type" benzodiazepine receptors has been postulated.

This

hypothesis was initially based on the pharmacology of the
triazolopyridazine, CL218,872, in different brain regions (Squires et
al, 1979; Klepner et al, 1979).

Autoradiographic studies at the light

microscopic level seemed to corroborate this finding (Young & Kuhar,
1980; Young et al, 1981).

This agreement was not absolute, however,

as CL218,872 binding in cerebellum suggested a single receptor
subtype,

whereas

autoradiography

heterogeneity (Niehoff et al, 1982).

demonstrated

receptor

Several laboratories have

reported the photolabeling of benzodiazepine receptor subtypes in
the hippocampus and striatum (BZi and BZ2), whereas photo-labeling
in cerebellum revealed only a single receptor subtype (BZX).
Although such regional heterogeneity might offer a tenable
explanation for the two major receptor subtypes seen, recent

■
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evidence suggests that these subtypes may in fact be subunits of a
single receptor species.

Photo-labeling studies using the GABA

agonist [3H]muscimol demonstrate labeling of the beta subunit in
bovine brain (Casalotti et al, 1986).

Monoclonal antibodies to the

bovine benzodiazepine receptor demonstrate the 55 kD protein in all
brain regions studied, including the cerebellum (Haring et al, 1985).
Furthermore, by immunoprecipitation with either of two monoclonal
antibodies recognizing the different "receptor proteins", this group
was able to demonstrate co-precipitation of the entire population of
binding sites (benzodiazepine, as well as low and high affinity GABA)
found in their purified preparations.

These results were interpreted

to suggest the existence of a homogenous population of
GABAa/benzodiazepine receptors comprised of two different receptor
protein subunits (alpha and beta).

Thus, multiple subunits of a large

macromolecular complex, rather than receptor heterogeneity may
account for the 50 and 55 kD bands.
As noted above, allosteric properties of the receptor complex
remain intact in our partially purified preparation, implicating
conformational integrity of the GABA/benzodiazepine receptor
complex.

With this in mind, attempts to further purify the receptor

complex on the basis of its macromolecular size were pursued.

Gel

exclusion chromatography on Sephadex G-200 enabled enhancement
of the major bands (48.5 kD, 54.5 kD).

Many bands of higher and

lower molecular weights, as well as the 50 kD band, eluted later from
the column.

The early elution of the major bands with the blue

dextran marker (Mr= 2000 kD) is consistent with the possibility of
their association as a large macromolecular complex.

Utilizing a

■
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variety of approaches, investigators have implicated the
GABA/benzodiazepine receptor complex to have an apparent
molecular weight of 200 - 900 kD (as review by Fischer & Olsen,
1986).

In particular, by methods of gel filtration chromatography,

the native receptor has been estimated to have a molecular weight of
220 kD (Yosufi et al, 1979; Chang & Barnard, 1982; Martini et al,
1982; Fischer & Olsen, 1986).

Thus, the exclusion size of the

Sephadex G-200 would be expected to result in elution of the
receptor complex with the void volume as seen with the 48.5 and
54.5 kD bands.
With the knowledge that the 48.5 kD and 54.5 kD proteins
(alpha and beta subunits) shared a common immunoreactive epitope,
it remained interesting to speculate about potential homology
between these two proteins.

Though much work in the field has

focused on the apparent heterogeneity or multiplicity of
benzodiazepine receptor proteins, few studies have sought to explore
at a molecular level their relatedness.

The question of homology was

approached using methods of limited proteolytic degradation.

In

order to adequately visualize peptide fragments, the receptor was
first iodinated and results determined by autoradiography.

By

subjecting the major protein bands in our highly purified receptor
preparation to SAP digestion, it was possible to generate a proteolytic
map or "fingerprint" of the receptor.
Results show that all of the major bands were susceptible to
degradation by the V8 protease within the same concentration range
(0.001 - 0.03 jig). The peptide fragments visualized by
autoradiography may not represent the "complete" peptide map of
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these proteins due to variable incorporation of the 125I-BH based on
amino acid composition.

Nevertheless, limiting peptides

characteristic of individual bands were generated.

Most striking

among these were those of the 48.5 and 54.5 kD bands.

Although

variations in their limited peptide maps exist, both proteins
demonstrate 2 major limiting peptides of apparent molecular weights
21 and 23 kD.

This reproducible peptide pattern may represent

some degree of homology at the level of primary protein structure.
Interpretation of this data was supplemented by
electrophoresis of the iodinated preparation in two dimensions.
Isoelectric focusing of the 48.5 band demonstrated its homogeneity
with a pi in the acidic range (approximately 4.8 ).

The 54.5 band,

however, appeared to be comprised of several distinct protein foci.
The peptide map of this band, therefore, may represent the
combined pattern of several, potentially unrelated proteins.
Interestingly, both the 54.5 and 58 kD bands seem to share the
protein spots with pi's of approximately 6.0.

Whether these protein

foci represent distinctly different proteins with differing primary
structure is uncertain.

Alternatively, their similar pi's might be

explained by slight differences in carbohydrate content of an
otherwise identical protein molecule.

Cleavage of a small, neutral

peptide, be it physiological or artifactual, might account for the
molecular weight differences.

In the peptide maps of the 54.5 and

58 kD bands, faint bands of identical molecular weight can be seen.
Based on similar pi values and apparently shared proteolytic
fragments, it remains interesting to speculate that these various foci
represent the same primary protein.

In addition to these proteins,
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the 54.5 kD band is comprised of a larger, more basic (pi-6.5-7.0)
protein.

The more diffuse focusing of this protein may represent an

artifact of the gradient at the more basic spectrum, or might again be
explained by variable glycosylation of the same protein.

Both 58 and

68 kD proteins demonstrated unique peptide maps, distinct from
either of the two lower molecular weight bands.

The shared limiting

peptides of the 48.5 and 54.5 kD bands may thus be the result of
homology between the more basic 54.5 kD protein (pl=6.5-7.0) and
the 48.5 kD band.

Immunoblot studies to two dimensional gels with

the monoclonal antibody H10 may serve to clarify this relationship.
In tryptic digest experiments done by Eichinger & Sieghart
(1985), they demonstrated differential degradation of 3HFlunitrazepam-labeled 51 and 55 kD proteins.

They cite this

differential degradation pattern as supportive evidence of different
receptor subtypes.

Analysis of their data shows that although tryptic

degradation results in different major limiting peptides, tryptic
digestion of the 51 kD protein generates minor bands of 42 and 45
kD.

These appear identical to the major [3H]Flunitrazepam-labeled

limiting peptide fragments (42 and 45 kD) characteristic of the 55 kD
band.

Thus, though interpreted to implicate receptor heterogeneity,

an argument for structural homology between the same two proteins
can be made.

Because the fragments generated in their experiments

represent photo-labeled peptides, such results would implicate
homology at the benzodiazepine binding portion of the receptor.
present, it is not possible from our data to ascribe homology to a
given receptor domain.

Proteolytic experiments utilizing photo-

labeled receptor remain to be done.

In addition,

immunoblot

At
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experiments using our monoclonal antibodies against these
proteolytic maps may enable identification of peptide epitopes,
either that specific for the 48.5 or that shared by both the 48.5 and
55 kD proteins.

Until the various receptor bands are cloned and their

sequences defined, such lines of investigation may help to elucidate
the relatedness of these various proteins and their relationship to the
GABAa /benzodiazepine receptor.
In addition to the 48.5 and 54.5 kD proteins discussed above,
several other proteins are observed in our partially purified receptor
preparation (50 kD, 58 kD and 68 kD).

The identity of these bands is

uncertain, although they remain unrecognized by our monoclonal
antibodies, and the two larger proteins demonstrate unique peptide
maps different from either the 48.5 or the 54.5 kD bands.

Although

these protein bands may be regarded as contaminants, other possible
explanations for their co-purification exist.

Several proteins may in

fact co-purify by our affinity chromatography methods based on
their ability to bind benzodiazepines.

Even proteins with low

affinities for the benzodiazepines, if present in large amounts in
tissue, might be expected to represent a significant constituent of the
partially purified preparation.

Albumin, for example, is known to

bind numerous drugs, including the benzodiazepines (Fehske et al,
1979).

In addition, other "peripheral" receptors for the

benzodiazepines have described, including a low affinity (pM) Ca2+Calmodulin kinase associated receptor (Bowling & DeLorenzo, 1982).
A second, and as yet unexplored possibility, is that various
bands in our preparation represent different stages in the posttranslational modification of the receptor.

It has been demonstrated
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that the receptor is a glycoprotein (Gavish & Snyder, 1981;
Stephenson & Olsen, 1983; Sweetnam & Tallman, 1986).
Glycosylated versus non-glycosylated, as well as "pre-" and "pre/pro" forms of the receptor might account for observed "heterogeneity".
In addition, multiple allelic variants
within the genome may exist.

of the benzodiazepine receptor

Such genetic variation in enzymes

("isozymes") is a well documented phenomenon in both physiologic
and pathophysiologic states in the human.

Though no example of

such an "iso-receptor" has been demonstrated to date, allelic variants
of the benzodiazepine receptor would have significant implications
for many neurologic and psychiatric disorders.
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Legends to Figures

Figure 1.

Partially purified benzodiazepine receptor preparation

(Bzr) was run under standard 7.5% SDS-PAGE conditions and
visualized by coomassie blue staining as described in "Materials &
Methods."

A major protein band of 48.5 kD is seen, as well as other

minor bands (50, 54.5, 58, and 68 kD).

A reference lane of low

molecular weight standards (Std) is shown, as well.

Figure 2.

The partially purified benzodiazepine receptor

preparation was subjected to gel exclusion chromatography as
described in "Materials & Methods."

Fractions were collected

beginning with elution of the Dextran Blue front and were then
subjected to standard 7.5% SDS-PAGE analysis.

As seen here,

fractions 1-8 elute with the Dextran Blue and are enhanced
48.5, 54.5, 58, and 68 kD bands.
Sample 1.

in the

These fractions were pooled as

The 50 kD band elutes later (fractions 9-20) and was

pooled separately as Sample 2.

Reference lanes containing low

molecular weight standards (Std) and partially purified
benzodiazepine receptor preparation (Bzr) are also shown.

Figure 3.

Benzodiazepine receptor fractions collected following gel

exclusion chromatography of the partially purified preparation were
pooled as shown in Figure 2.

The pooled fractions, Samples 1 and 2,

were then subjected to standard 7.5% SDS-PAGE and coomassie blue
staining as described in "Materials & Methods."

Sample 1 shows

relative enhancement of the 48.5, 54.5, 58, and 68 kD bands and was
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saved for iodination and subsequent limited proteolysis.

Sample 2 is

contains the 50 kD, as well as other higher and lower molecular
weight bands separated by gel exclusion purification.

Reference

lanes containing low molecular weight standards (Std) and partially
purified benzodiazepine receptor preparation (Bzr) are also shown.

Figure 4.

Balb-C mice were immunized using the partially purified

benzodiazepine receptor preparation. Sera obtained from each mouse
before, following primary, and following secondary immunizations
was subjected to solid phase radioimmunoassay as outlined in
"Materials & Methods."

As shown here, immunization resulted in

increasing titers of polyclonal sera following each step.

Mice with the

highest polyclonal titers were then identified for generation of
hybridoma cell lines.

Figure 5.

High titer ascites from 6 murine monoclonal cell lines was

tested by solid phase radioimmunoassay as described in "Materials &
Methods."

Results here show significant activity at dilutions of

1:1000 to 1:10,000.

Monoclonals E9 and H10 demonstrate

considerable activity at higher dilutions (1:10,000) and were used for
subsequent immunoblot experiments.

Figure 6.

Partially

purified

benzodiazepine

receptor

preparation

was subjected to SDS-PAGE and subsequent transverse
electrophoresis onto nitrocellulose as described in "Material &
Methods."

Immunoblots to the nitrocellulose fixed receptor using E9,

H10, and control ascites at dilutions of 1:1000 are shown.

Low
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molecular weight standards (Std) and receptor preparation (Bzr)
subjected to SDS-PAGE and coomassie blue staining are included for
reference.

Two immunoreactive proteins with apparent molecular

weights of 48.5 and 54.5 kD can be seen.

Antibody produced by the

monoclonal cell line E9 is specific for the 48.5 kD or alpha subunit.
H10j however, demonstrates cross-reactivity
(alpha) and 54.5 kD (beta subunit) bands.

between both the 48.5
Subsequent subcloning

has shown a single antibody to be responsible for this dual
recognition.

Figure 7.

Purified benzodiazepine receptor obtained by affinity and

gel exclusion chromatography methods was subjected to iodination as
described in "Materials & Methods."

The profile of radioactivity

eluted from the Sephadex G-50 column is shown here.
radioactive peaks can be seen to elute from the column.

Two
The minor

peak appearing with the void volume represents the iodinated
receptor

(125I-BZR) as demonstrated in Figure 8.

The second, major

peak most likely represents Bolton/Hunter reagent coupled to
glycine.

Figure 8.

Following elution of the iodinated benzodiazepine

receptor from the Sephadex G-50 column, individual fractions were
sampled (5pl) and analyzed by 7.5% SDS-PAGE and autoradiography
as described in "Materials & Methods."

The autoradiogram

demonstrates the iodinated receptor (125I-BZR) in fractions 2-5, the
first peak seen in Figure 2.

■
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Figure 9.

The iodinated benzodiazepine receptor was run under

7.5% SDS-PAGE conditions, 58 kD and 54.5 kD bands cut from the gel,
and the gel slices subjected to limited proteolysis on 15% SDS-PAG's
as described in "Materials & Methods."

The autoradiogram pictures

the individual bands in the absence of staph, aureus V8 protease
(SAP) in lanes 1.

Lanes 2-5 demonstrate increasing degradation of

the original protein bands into limiting peptide fragments in the
presence of 0.001, .003, 0.01, and 0.03 jig of SAP, respectively.
iodinated receptor is included for reference.

The

In addition, arrows

indicate appropriate positions of the low molecular weight standards.

Figure

10.

The iodinated benzodiazepine receptor was run under

7.5% SDS-PAGE conditions, 68 kD and 48.5 kD bands cut from the gel,
and the gel slices subjected to limited proteolysis on 15% SDS-PAG's
as described in "Materials & Methods."

The autoradiogram pictures

the individual bands in the absence of staph, aureus V8 protease
(SAP) in lanes 1.

Lanes 2-5 demonstrate increasing degradation of

the original protein bands into limiting peptide fragments in the
presence of 0.001, .003, 0.01, and 0.03 pg of SAP, respectively.
iodinated receptor is included for reference.

The

In addition, arrows

indicate appropriate positions of the low molecular weight standards.

Figure

11.

Limited proteolysis of the 68, 58, 54.5, and 48.5 kD

bands was conducted in parallel using identical SAP conditions as
described in "Materials & Methods."

As seen from left to right, the

68, 58, 54.5, and 48.5 kD bands were run in the absence (1), with
0.001 pg (2), and with 0.01 pg (3) of SAP.

Comparison of the
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neighboring peptide maps demonstrate the presence of two shared
limiting peptides (21 and 23 kD) by the 48.5 and 54.5 kD bands.

A

sharply focussed U-shaped band positioned between the 21 and 23
kD peptide fragments of the 54.5 kD band represents artifact (see
figure 9 for comparison).

Figure 12.

Utilizing 2D gel analysis as described in "Materials &

Methods" the iodinated benzodiazepine receptor preparation was
examined.

The major 48.5 kD protein appears homogeneous in

composition and has a pi value of approximately 4.8.
band appears as a single spot at around pH 4.7.

The 68 kD

Both the 54.5 and 58

kD bands can be seen to resolve into multiple spots with different
pi's.

Several of these with pi's of approximately 6.0 appear to be

duplicated in both 54.5 and 58 kD bands.

In addition, the 54.5 kD

band is composed of a more basic protein spot having a pi of 6.5-7.0.

Figures 13 & 14.

In

parallel

experiments,

whole

photo-labeled

membranes were subjected to 2D electrophoresis on three sister gels
as described in "Materials & Methods."
protein by coomassie blue (A):
acidic (pi's 4.5-7.0).

The first was stained for total

this revealed proteins to be generally

The second gel was subjected to

autoradiography (B) and the third was immunoblotted with E9
ascites.

These gels reveal a single major protein spot with pi's

identical to the 48.5 kD protein of the iodinated receptor preparation
(Figure 12) and the partially purified receptor preparation as
visualized by coomassie blue staining (D).
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